The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

(2015) M. R. Russell et al.   CANCER RESEARCH

Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer

(2015) A. Mehta et al.   ENDOCRINE-RELATED CANCER

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism

(2015) Derek A. Oldridge et al.   NATURE

Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk

(2014) M. Capasso et al.   CANCER RESEARCH

Rare Variants in TP53 and Susceptibility to Neuroblastoma

(2014) Sharon J. Diskin et al.   JNCI-Journal of the National Cancer Institute

Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells

(2013) Lan Qiao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis

(2013) Heping Xiang et al.   MOLECULAR BIOLOGY REPORTS

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity

(2012) K. R. Bosse et al.   CANCER RESEARCH

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

(2012) Mario Capasso et al.   CARCINOGENESIS

p27Kip1 Is a Microtubule-Associated Protein that Promotes Microtubule Polymerization during Neuron Migration

(2012) Juliette D. Godin et al.   DEVELOPMENTAL CELL

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

(2012) Sharon J Diskin et al.   NATURE GENETICS

Improved whole-chromosome phasing for disease and population genetic studies

(2012) Olivier Delaneau et al.   NATURE METHODS

Association of Genetic Polymorphisms in Cell-Cycle Control Genes and Susceptibility to Endometrial Cancer Among Chinese Women

(2011) Hui Cai et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci

(2011) Lễ B. Nguyễn et al.   PLoS Genetics

Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their Application

(2010) Rita M. Cantor et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Allelic variant at −79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels

(2010) Iñigo Landa et al.   ENDOCRINE-RELATED CANCER

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

(2010) Kai Wang et al.   NATURE

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

(2009) Mario Capasso et al.   NATURE GENETICS

Alternative Functions of Core Cell Cycle Regulators in Neuronal Migration, Neuronal Maturation, and Synaptic Plasticity

(2009) Christopher L. Frank et al.   NEURON

A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies

(2009) Bryan N. Howie et al.   PLoS Genetics

Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma

(2008) John M. Maris et al.   NEW ENGLAND JOURNAL OF MEDICINE

In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines

(2008) Anjali Gaikwad et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE